GHRP-6: A Laboratory Research Reference

GHRP-6 (growth hormone-releasing peptide 6) is a synthetic hexapeptide that acts as an agonist at the growth hormone secretagogue receptor. It is studied in laboratory research for its influence on growth hormone release in experimental models.

This page is a non-promotional scientific reference for researchers. It summarises the chemical identity, molecular characteristics, mechanism as described in the literature, research areas, and analytical testing of GHRP-6. It does not provide dosing, therapeutic, or human-use guidance of any kind. GHRP-6 supplied by Bulk Aussie Peptides is for laboratory research purposes only.

What Is GHRP-6?

GHRP-6 is a synthetic growth hormone-releasing peptide developed from work optimising met-enkephalin-derived sequences. Early studies showed that certain short synthetic peptides could stimulate growth hormone release without acting at the GHRH receptor, and GHRP-6 became a reference compound for the class. Its synthetic, single-sequence nature makes it a convenient tool for studying the growth hormone secretagogue receptor.

For background on how synthetic research peptides are produced and verified, see the synthetic peptides research guide.

Molecular Characteristics

Several molecular properties are used to identify GHRP-6 in analytical documentation:

• Classification: a synthetic growth hormone-releasing peptide, a member of the growth hormone secretagogue receptor agonist family.
• Sequence: a six-amino-acid peptide, conventionally written His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂.
• Molecular weight: reported in Daltons (Da) on product documentation; the measured value on a Certificate of Analysis should be compared against the theoretical mass derived from the sequence.
• Physical form: supplied as a lyophilised (freeze-dried) powder, the standard presentation for research peptides.

How GHRP-6 Works

GHRP-6 acts as an agonist at the growth hormone secretagogue receptor (GHS-R), the molecular target through which ghrelin exerts its activity. In laboratory models, activation of this receptor is associated with signalling through phosphoinositide turnover, a pathway distinct from the cyclic AMP signalling used by GHRH. The growth hormone-releasing effect of GHRP-6 appears to depend on the presence of endogenous GHRH, indicating that the two pathways act in concert in experimental endocrine models.

These observations are preclinical and describe receptor pharmacology in model systems; they do not constitute a therapeutic use.

Areas of Scientific Research

The research literature describes several lines of investigation involving GHRP-6:

• Growth hormone secretagogue receptor pharmacology: characterisation of receptor binding and signal transduction.
• Growth hormone release: studies of pulsatile growth hormone secretion in experimental endocrine models.
• Pathway interplay: work examining how the GHRP and GHRH pathways interact to influence growth hormone output.

These investigations are conducted in vitro or in approved animal research models under institutional oversight. They do not translate to approved human use.

Analytical Testing

As with other research peptides, GHRP-6 is characterised using:

• HPLC for purity assessment, reported as a percentage of total peak area.
• Mass spectrometry for identity confirmation, by comparing measured molecular mass to the theoretical value.

Guidance on interpreting the resulting documents is available in the article on how to read a peptide Certificate of Analysis.

Storage and Handling

In a laboratory context, lyophilised GHRP-6 is typically stored in a freezer, protected from light and moisture, and handled according to the product-specific documentation. Once reconstituted, the resulting solution is refrigerated and used within the timeframe stated in the documentation. General guidance is covered in the peptide storage and stability reference.

Frequently Asked Questions

• What is GHRP-6? GHRP-6 is a synthetic six-amino-acid growth hormone-releasing peptide.
• What receptor does GHRP-6 target? It acts as an agonist at the growth hormone secretagogue receptor (GHS-R).
• How does GHRP-6 differ from GHRH? GHRP-6 acts at the secretagogue receptor rather than the GHRH receptor and signals through a distinct pathway.
• What is GHRP-6 studied for? It is investigated in laboratory models for GHS-R pharmacology and growth hormone release.
• How is GHRP-6 purity tested? Purity is commonly estimated by HPLC, while identity is confirmed by mass spectrometry.

References

• Cheng, K., Chan, W. W.-S., Barreto, A., Convey, E. M., & Smith, R. G. (1989). The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3′,5′-monophosphate accumulation in rat primary pituitary cell culture. Endocrinology, 124(6), 2791–2798. PubMed 2542009
• Bowers, C. Y., Momany, F. A., Reynolds, G. A., & Hong, A. (1984). On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology, 114(5), 1537–1545. PubMed 6143660

Related Research Resources

• Hexarelin: A Laboratory Research Reference — a related metabolically stabilised GHRP.
• Ipamorelin: A Laboratory Research Reference — another secretagogue peptide.
• Synthetic Peptides: Research Guide — how research peptides are produced and verified.